Associations of Oral Contraceptives with Mammographic Breast Density in Premenopausal Women
- PMID: 34862209
- PMCID: PMC8825703
- DOI: 10.1158/1055-9965.EPI-21-0853
Associations of Oral Contraceptives with Mammographic Breast Density in Premenopausal Women
Abstract
Background: We investigated the associations of oral contraceptives (OC) with percent breast density (PD), absolute dense area (DA), nondense area (NDA), and a novel image intensity variation (V) measure in premenopausal women.
Methods: This study included 1,233 controls from a nested case-control study within Nurses' Health Study II cohort. Information on OCs was collected in 1989 and updated biennially. OC use was defined from the questionnaire closest to the mammogram date. PD, DA, and NDA were measured from digitized film mammograms using a computer-assisted thresholding technique; the V measure was obtained with a previously developed algorithm measuring the SD of pixel values in the eroded breast region. Generalized linear regression was used to assess associations between OCs and density measures (square root-transformed PD, DA, and NDA, and -untransformed V).
Results: OC use was not associated with PD [current vs. never: β = -0.06; 95% confidence interval (CI), -0.37-0.24; past vs. never: β = 0.10; 95% CI, -0.09-0.29], DA (current vs. never: β = -0.20; 95% CI -0.59-0.18; past vs. never: β = 0.13; 95% CI, -0.12-0.39), and NDA (current vs. never: β = -0.19; 95% CI, -0.56-0.18; past vs. never: β = -0.01; 95% CI, -0.28-0.25). Women with younger age at initiation had significantly greater V-measure (<20 years vs. never: β = 26.88; 95% CI, 3.18-50.58; 20-24 years vs. never: β = 20.23; 95% CI, -4.24-44.71; 25-29 years vs. never: β = 2.61; 95% CI -29.00-34.23; ≥30 years vs. never: β = 0.28; 95% CI, -34.16-34.72, P trend = 0.03).
Conclusions: Our findings suggest that an earlier age at first OC use was associated with significantly greater V.
Impact: These findings could guide decisions about the age for OC initiation.
©2021 American Association for Cancer Research.
Conflict of interest statement
Conflict of interest
The authors declare that they have no conflict of interest.
Similar articles
-
Adolescent caffeine consumption and mammographic breast density in premenopausal women.Eur J Nutr. 2020 Jun;59(4):1633-1639. doi: 10.1007/s00394-019-02018-0. Epub 2019 May 31. Eur J Nutr. 2020. PMID: 31152213 Free PMC article.
-
Associations of aspirin and other anti-inflammatory medications with mammographic breast density and breast cancer risk.Cancer Causes Control. 2020 Sep;31(9):827-837. doi: 10.1007/s10552-020-01321-0. Epub 2020 May 31. Cancer Causes Control. 2020. PMID: 32476101 Free PMC article.
-
Associations of coffee consumption and caffeine intake with mammographic breast density.Breast Cancer Res Treat. 2018 May;169(1):115-123. doi: 10.1007/s10549-018-4667-4. Epub 2018 Jan 17. Breast Cancer Res Treat. 2018. PMID: 29340883 Free PMC article.
-
Interactions of alcohol and postmenopausal hormone use in regards to mammographic breast density.Cancer Causes Control. 2018 Aug;29(8):751-758. doi: 10.1007/s10552-018-1053-9. Epub 2018 Jun 25. Cancer Causes Control. 2018. PMID: 29938357 Free PMC article.
-
Neoplastic effects of oral contraceptives.Int J Fertil. 1991;36 Suppl 1:19-24. Int J Fertil. 1991. PMID: 1678377 Review.
Cited by
-
The Correlation Between Progesterone and Mammographic Density in Postmenopausal Women: A Systematic Review of the Literature and Meta-Analysis.Cureus. 2023 Sep 20;15(9):e45597. doi: 10.7759/cureus.45597. eCollection 2023 Sep. Cureus. 2023. PMID: 37868563 Free PMC article. Review.
References
-
- McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15(6):1159–69 - PubMed
-
- Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2007;99(15):1178–87 - PubMed
-
- Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev 2013;22(11):1931–43 - PubMed
-
- Health NIo. 2018. Oral Contraceptives (Birth Control Pills) and Cancer Risk - National Cancer Institute. <https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/oral...>.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous